Mallinckrodt Plc (MNKKQ) Return on Investment ROI from the second quarter of 2026 to second quarter of 2022 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Apr 01 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mallinckrodt Plc  (MNKKQ)


Mallinckrodt Plc's ROI from its second quarter of 2026 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mallinckrodt Plc's ROI in the second quarter of 2026?
Mallinckrodt Plc achieved a return on average invested assets (ROI) of 4.65 % in its second quarter of 2026, this is above MNKKQ's average return on investment of -4.78%.
Mallinckrodt Plcs investments during the 12 months ending in the second quarter of 2026 are valued at $4 billion

ROI decreased relative to the period ending Jun 27 2025, due to the decline in net income.

Within the Healthcare sector 232 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3789, from total ROI ranking in the second quarter of 2025 at 3928.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Jun 27 2025)
II. Quarter		 (Dec 27 2024)
IV. Quarter		 (Jun 16 2022)
II. Quarter		 (Apr 01 2022)
I. Quarter
Y / Y Investment Change TTM -39.17 % -30.8 % 3.65 % 23.61 % 24.49 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 4,553 3,096 2,794 6,858 7,067
Return On Investment (TTM) 4.65 % 6.1 % 1.6 % -11.1 % -9.75 %
MNKKQ's Overall Ranking # 3789 # 3928 # 3305 # 3158 # 3584
Seq. Investment Change TTM -12.69 % -17.06 % -15.06 % -1.1 % -0.67 %
Seq. Net Income Change TTM -33.4 % 215.67 % - - -
Net Income (TTM) in Millions 201 302 96 -781 -693

MNKKQ Company Profile >> Back to MNKKQ Roi Comparisons >> See Annual MNKKQ Return On Investment



Return On Investment MNKKQ's Ranking
Within: No.
Industry # 81
Sector # 233
Overall # 3789

Return On Investment Statistics
High Average Low
15.84 %
-4.78 %
-38.36 %
(Dec 29 2017)   (Sep 27 2019)







Financial Statements
Mallinckrodt Plc's II. Quarter Investments $ 4,553 Millions MNKKQ's Balance sheet
Mallinckrodt Plc's II. Quarter Income $ -221 Millions Quarterly MNKKQ's Income Statement
MNKKQ's Income by Division See MNKKQ's Income by Division


MNKKQ Annual Return On Investment (Dec 27 2024)
2024		 (Dec 31 2021)
2021		 (Dec 25 2020)
2020		 (Dec 27 2019)
2019		 (Dec 28 2018)
2018
Total Investments in Millions 2,794 6,974 5,597 7,269 9,934
Y / Y Investment Growth -59.94 % 24.61 % -23 % -26.83 % -30.2 %
Net Income in Millions 478 -717 -945 -997 -3,607
Y / Y Net Income Growth - - - - -
Annual Return On Investment 17.11 % -10.29 % -16.88 % -13.71 % -36.31 %


Annual Roi Comment
In the fiscal year 2024 ROI improved to 17.11 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MNKKQ's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MNKKQ's Competitors
Subscribers only: Roi for Mallinckrodt Plc's Suppliers
Subscribers only: Return On Investment for MNKKQ's Customers

Other Ratios
MNKKQ's Roa MNKKQ's Inventory Turnover Ratio MNKKQ's Growth Rates MNKKQ's Dividend Statistics
MNKKQ's Profitability Ratios MNKKQ's Asset Turnover Ratio MNKKQ's Dividend Growth
MNKKQ's Roe MNKKQ's Valuation Ratios MNKKQ's Financial Strength Ratios MNKKQ's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %
National Healthcare Corp  10.91 %
Bioventus Inc   10.85 %
Infusystem Holdings Inc  10.53 %
Livanova Plc  10.40 %
Beone Medicines Ltd   10.32 %
Entrada Therapeutics Inc   10.15 %
Jazz Pharmaceuticals Plc  10.06 %
Prestige Consumer Healthcare Inc   10.06 %
Tactile Systems Technology Inc   10.02 %
Tenet Healthcare Corp  9.98 %
Nature s Sunshine Products inc   9.91 %
Boston Scientific Corporation  9.91 %
Align Technology inc   9.50 %
Pediatrix Medical Group Inc   9.18 %
Abbvie Inc   9.11 %
Ani Pharmaceuticals Inc  9.09 %
Viemed Healthcare Inc   8.97 %
Stryker Corp  8.80 %

Date modified: 2026-09-26T06:54:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.